Clinical Trial Update: Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial for IL-1 blockade in acute myocardial infarction has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Acute Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-12-18